Newsroom
Press Releases
Koronis Pharmaceuticals to Present at 2010 BIO International Convention (April 29, 2010)
READ MORE >>
Koronis Appoints Rondaxe To Secure Commercialization Partner For KP-1461, Possible Cure For HIV (April 28, 2010)
READ MORE >>
Koronis Pharmaceuticals' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation (May 19, 2009)
READ MORE >>
Koronis Pharmaceuticals Announces Appointment of Prominent HIV Researcher Courtney Fletcher, Pharm. D., to Scientific Advisory Board and Jeff Parkins as VP, Clinical Development (September 30, 2008)
READ MORE >>
Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development (February 7, 2008)
READ MORE >>
Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors (January 31, 2008)
READ MORE >>
News Coverage
Genetic Engineering News: Need for Novel Approaches to Treating HIV Still Exists
Patricia F. Diamond, Ph.D., Genetic Engineering News, July 31, 2009
The New Virus Killer: Scientists try to turn HIV’s greatest strength—mutation—against itself
Gregory Mone, POPSCI.com, January 15, 2009
From Soup to Nuts
Drug Discovery & Development, April 01, 2008
Why Are Evolutionary Biologists Bringing Back Extinct Deadly Viruses?
The New Yorker, Annals of Science, Darwin’s Surprise, December 3, 2007
New Kind of Antiretroviral, KP-1461; Clinical Trial Recruiting
AIDS Treatment News, October 11, 2007
KP-1461 Novel Agent Enters Phase 2a Proof-of-Concept Study
Positively Aware, September/October 2007
Selected Articles
Dr. James Mullins Abstract - International HIV & Hepatitis Virus Drug Resistance Conference
Dr. James Mullins, June 9th, 2010
New HIV Drug Development a Problem
Jules Levin, December 4, 2008
2007 - A Look Back Over 20 Years
Mary Katz, MD, Being Alive Winter 2008 Newsletter
Stay Informed
To keep updated on Koronis' latest events and news releases, please go to our contact page and enter your name and email address to be added to our email news distribution list.